Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women

NCT01742000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DIETARY_SUPPLEMENT: Karinat
DRUG: Placebo

Sponsor

Institute for Atherosclerosis Research, Russia